Eris Lifesciences has reported results for third quarter ended December 31, 2018.
The company has reported a rise of 6.71% in its net profit at Rs 78.88 crore for the quarter under review as compared to Rs 73.92 crore for the same quarter in the previous year. Total income of the company increased by 28.02% at Rs 240.96 crore for Q3FY19 as compared Rs 188.22 crore for the corresponding quarter previous year.
On the consolidated basis, the company has reported a rise of 7.41% in its net profit at Rs 80.14 crore for the quarter under review as compared to Rs 74.61 crore for the same quarter in the previous year. Total income of the company increased by 22.31% at Rs 262.68 crore for Q3FY19 as compared Rs 214.76 crore for the corresponding quarter previous year.
